XML 126 R12.htm IDEA: XBRL DOCUMENT v3.23.1
Segment Information
 3 Months Ended
Mar. 31, 2023
Segment Reporting [Abstract]  
Segment Information SEGMENT INFORMATION
The Company operates and reports its results in four separate business segments consisting of the Biotechnology, Life Sciences, Diagnostics, and Environmental & Applied Solutions segments. When determining the reportable segments, the Company aggregated operating segments based on their similar economic and operating characteristics. Operating profit represents total revenues less operating expenses, excluding nonoperating income and expense, interest and income taxes. Operating profit amounts in the Other segment consist of unallocated corporate costs and other costs not considered part of management’s evaluation of reportable segment operating performance. Intersegment amounts are not significant and are eliminated to arrive at consolidated totals.
Segment results are shown below ($ in millions):
 Three-Month Period Ended
March 31, 2023April 1, 2022
Sales:
Biotechnology$1,864 $2,216 
Life Sciences1,709 1,666 
Diagnostics2,376 2,644 
Environmental & Applied Solutions1,218 1,162 
Total$7,167 $7,688 
Operating profit:
Biotechnology$596 $800 
Life Sciences321 318 
Diagnostics677 886 
Environmental & Applied Solutions299 236 
Other(99)(68)
Total$1,794 $2,172